Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911



 Company News
Celldex (CLDX)'s Varlilumab Demonstrates Synergistic Anti-Tumor Activity With PD-1 Signaling Blockade In Preclinical Studies 4/20/2015 8:42:33 AM
Celldex (CLDX)' Phase 2 EMERGE Study Of Glembatumumab Vedotin In Metastatic Breast Cancer Published In Journal Of Clinical Oncology 4/7/2015 6:53:22 AM
Celldex (CLDX) Announces Initiation Of Phase 1/2 Study Of Varlilumab In Combination With Ipilimumab And CDX-1401 In Metastatic Melanoma 4/6/2015 7:05:39 AM
TaiGen Biotechnology Announces Burixafor Collaboration With Celldex (CLDX) And The University Hospital Carl Gustav Carus Dresden In Germany 3/18/2015 6:39:31 AM
Celldex (CLDX) Announces Clinical Trial Collaboration With Roche (RHHBY) To Evaluate The Combination Of Varlilumab And MPDL3280A 3/17/2015 7:26:21 AM
Celldex (CLDX) Announces Upcoming Presentation At The Cowen and Company 35th Annual Health Care Conference 3/3/2015 8:36:27 AM
Celldex (CLDX) Announces Exercise Of Underwriters' Option To Purchase Additional Shares 3/2/2015 7:15:59 AM
Celldex (CLDX) Prices Public Offering Of Common Stock 2/26/2015 1:17:24 PM
Celldex (CLDX) Announces Proposed Public Offering Of Common Stock 2/25/2015 7:48:34 AM
Celldex (CLDX) Reports Fourth Quarter And Year-End 2014 Results 2/24/2015 10:34:29 AM